Abstract
We studied the frequency and time of appearance of antibodies to the hepatitis C virus (HCV) retrospectively in the sera of 127 patients who underwent heart surgery between 1983 and 1986. They received blood from volunteer donors hepatitis B surface antigen (HBsAg) negative with normal serum alanine-aminotransferase levels. A prospective follow-up was carried out every 15 days for at least 6 months from the moment of the transfusion. Of the ten patients who developed biochemical criteria of post-transfusional non-A non-B hepatitis, six seroconverted to anti-HCV (60%). Of the other 117, two were already positive before transfusion (1.51%), one patient showed antibodies only in the first post-transfusional serum (passive transfer), and another two patients with no evidence of post-transfusional hepatitis developed HCV antibodies on the 90th day, remaining indefinitely (afterwards seroconversion without hepatitis); both patients' earlier sera were anti-HCV negative. Four (40%) of the ten patients with post-transfusional hepatitis did not develop any serum markers to known hepatotropic agents. Although these findings do not exclude a viral infection by these viruses, they are consistent with the involvement of an unidentified non-A, non-B, non-C agent.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aach R. D., Stevens C. E., Hollinger F. B., Mosley J. W., Peterson D. A., Taylor P. E., Johnson R. G., Barbosa L. H., Nemo G. J. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med. 1991 Nov 7;325(19):1325–1329. doi: 10.1056/NEJM199111073251901. [DOI] [PubMed] [Google Scholar]
- Aach R. D., Szmuness W., Mosley J. W., Hollinger F. B., Kahn R. A., Stevens C. E., Edwards V. M., Werch J. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med. 1981 Apr 23;304(17):989–994. doi: 10.1056/NEJM198104233041701. [DOI] [PubMed] [Google Scholar]
- Alter H. J., Purcell R. H., Holland P. V., Alling D. W., Koziol D. E. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA. 1981 Aug 7;246(6):630–634. [PubMed] [Google Scholar]
- Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
- Bukh J., Miller R. H., Kew M. C., Purcell R. H. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1848–1851. doi: 10.1073/pnas.90.5.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bárcena Marugán R., Nash R., Pascasio J. M., Sáez de Santa-María J., Avilés J., García Hoz F., Moreira V. F., Cano A., Milicua J. M., Graus J. Prevalencia del anticuerpo al virus de hepatitis C en la hepatopatía crónica no alcohólica HBsAg negativa. Rev Esp Enferm Dig. 1992 Feb;81(2):117–120. [PubMed] [Google Scholar]
- Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
- Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
- Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
- Houghton M., Weiner A., Han J., Kuo G., Choo Q. L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991 Aug;14(2):381–388. [PubMed] [Google Scholar]
- Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
- Mattsson L., Aberg B., von Sydow M., Weiland O. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden. Scand J Infect Dis. 1991;23(1):25–29. doi: 10.3109/00365549109023370. [DOI] [PubMed] [Google Scholar]
- Miyamura T., Saito I., Katayama T., Kikuchi S., Tateda A., Houghton M., Choo Q. L., Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A. 1990 Feb;87(3):983–987. doi: 10.1073/pnas.87.3.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishioka K., Watanabe J., Furuta S., Tanaka E., Suzuki H., Iino S., Tsuji T., Yano M., Kuo G., Choo Q. L. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. Liver. 1991 Apr;11(2):65–70. doi: 10.1111/j.1600-0676.1991.tb00494.x. [DOI] [PubMed] [Google Scholar]
- Rodríguez M., Riestra S., San Román F., Pérez R., Suárez A., Sánchez J. L., Rodrigo L. Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories. Liver. 1991 Jun;11(3):129–133. doi: 10.1111/j.1600-0676.1991.tb00505.x. [DOI] [PubMed] [Google Scholar]
- Seeff L. B., Dienstag J. L. Transfusion-associated non-A, non-B hepatitis. Where do we go from here? Gastroenterology. 1988 Aug;95(2):530–533. [PubMed] [Google Scholar]
- Sugitani M., Inchauspé G., Shindo M., Prince A. M. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet. 1992 Apr 25;339(8800):1018–1019. doi: 10.1016/0140-6736(92)90538-e. [DOI] [PubMed] [Google Scholar]
- Tremolada F., Casarin C., Tagger A., Ribero M. L., Realdi G., Alberti A., Ruol A. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med. 1991 Feb 15;114(4):277–281. doi: 10.7326/0003-4819-114-4-277. [DOI] [PubMed] [Google Scholar]
- Wang J. T., Wang T. H., Lin J. T., Sheu J. C., Lin S. M., Sung J. L., Chen D. S. Recombinant immunoblot assay for hepatitis C antibody in patients with posttransfusion non-A, non-B hepatitis. J Med Virol. 1991 Jul;34(3):172–175. doi: 10.1002/jmv.1890340307. [DOI] [PubMed] [Google Scholar]
- Wang T. H., Wang J. T., Lin J. T., Sheu J. C., Sung J. L., Chen D. S. A prospective study of posttransfusion hepatitis in Taiwan. J Hepatol. 1991 Jul;13(1):38–43. doi: 10.1016/0168-8278(91)90861-5. [DOI] [PubMed] [Google Scholar]
- Widell A., Sundström G., Hansson B. G., Moestrup T., Nordenfelt E. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients. Vox Sang. 1991;60(1):28–33. doi: 10.1111/j.1423-0410.1991.tb00867.x. [DOI] [PubMed] [Google Scholar]
- Zaaijer H. L., Cuypers H. T., Reesink H. W., Winkel I. N., Gerken G., Lelie P. N. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993 Mar 20;341(8847):722–724. doi: 10.1016/0140-6736(93)90488-3. [DOI] [PubMed] [Google Scholar]
- van der Poel C. L., Reesink H. W., Lelie P. N., Leentvaar-Kuypers A., Choo Q. L., Kuo G., Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet. 1989 Aug 5;2(8658):297–298. doi: 10.1016/s0140-6736(89)90486-8. [DOI] [PubMed] [Google Scholar]
